Clinical Trial Update: Impact of Lymphocyte Anti-metabolite Immunosuppressions on Donor-Specific Anti-HLA Antibody and Kidney Graft Outcome [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the impact of lymphocyte anti-metabolite immunosuppressants on donor-specific anti-HLA antibodies and kidney graft outc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Kidney Transplant | Phase 4 | Status: COMPLETED